Literature DB >> 33128399

Impact of adjunctive procedures on recombinant human fibroblast growth factor-2-mediated periodontal regeneration therapy: A retrospective study.

Yohei Nakayama1,2, Hideo Matsuda1, Shoichi Itoh1, Yasunobu Iwai1, Hideki Takai1,2, Masaru Mezawa1,2, Shoichi Yoshino1, Yorimasa Ogata1,2.   

Abstract

BACKGROUND: Human fibroblast growth factor-2 (rhFGF-2) therapy has been used for periodontal tissue regeneration. However, few studies have reported their adjunctive procedures based on strategy of tissue engineering. The aim of this retrospective study is to assess the adjunctive effects of modified papilla preservation technique (mPPT) and combination with autogenous bone grafts (AG) on the rhFGF-2 therapy.
METHODS: Total of 44 sites underwent rhFGF-2 therapies and the evaluations in the survey periods. The primary outcome was set to the radiographic bone fill by radiographic examinations at 6 and 12 months after surgeries. We analyzed the correlation between influencing factors and the primary outcome, and differences of therapeutic effect by combination therapy with mPPT and that with AG.
RESULTS: After surgeries, probing depth (PD), clinical attachment level (CAL) and bone defects significantly improved. The improvements of radiographic bone fill were significantly positive correlated with a number of bone walls, combination with mPPT, and AG at 6 months after surgeries, and with combination with mPPT and AG at 12 months after surgeries. The significant differences of improvements of radiographic bone fill were demonstrated between combination with or without mPPT at 12 months after surgeries, and with or without AG at 6 and 12 months after surgeries. Moreover, the multiple linear regression analysis for the radiographic bone fill indicated the significant regression coefficient with conducts of mPPT.
CONCLUSIONS: mPPT and AG had powerfully adjunctive effects on rhFGF-2 therapy. Further studies are needed in order to verify by randomized clinical trials.
© 2020 American Academy of Periodontology.

Entities:  

Keywords:  bone graft(s); bone regeneration; periodontal regeneration; periodontitis

Year:  2020        PMID: 33128399     DOI: 10.1002/JPER.20-0481

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  2 in total

1.  Prognostic factors affecting periodontal regenerative therapy using recombinant human fibroblast growth factor-2: A 3-year cohort study.

Authors:  Risako Mikami; Takeaki Sudo; Shunsuke Fukuba; Kohei Takeda; Takanori Matsuura; Tomoaki Kariya; Shunsuke Takeuchi; Akane Ochiai; Sakurako Kawamoto; Keita Toyoshima; Koji Mizutani; Shinichi Arakawa; Akira Aoki; Takanori Iwata
Journal:  Regen Ther       Date:  2022-08-27       Impact factor: 3.651

2.  An exploratory clinical trial to evaluate the safety and efficacy of combination therapy of REGROTH® and Cytrans® granules for severe periodontitis with intrabony defects.

Authors:  Masahiro Kitamura; Motozo Yamashita; Koji Miki; Kuniko Ikegami; Masahide Takedachi; Yoichiro Kashiwagi; Takenori Nozaki; Katsuyuki Yamanaka; Hijiri Masuda; Yoko Ishihara; Shinya Murakami
Journal:  Regen Ther       Date:  2022-06-21       Impact factor: 3.651

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.